Prostate cancer, a condition affecting countless men worldwide, has long been synonymous with aggressive treatments like surgery and radiation. However, the landscape of prostate cancer care is evolving, offering new hope to patients seeking alternative, minimally invasive options. The groundbreaking technique is known as high-intensity focused ultrasound (HIFU).
Unlike traditional treatments that target the entire gland, HIFU's innovation lies in its precision. It selectively treats cancerous tissue while sparing the surrounding healthy tissue, drastically reducing the risk of common side effects such as urinary incontinence and erectile dysfunction.
Not all prostate cancers require the whole gland to be treated, making HIFU a valuable option. The ideal candidates are those with early-stage cancer confined to the prostate that’s visible on an MRI or ultrasound.
When it comes to recovery, HIFU typically takes one to three hours, and patients often go home the same day. Temporary catheterization and irritative urinary symptoms are expected initially but typically improve within a few weeks.